NCT00020410View on ClinicalTrials.gov

Radiolabeled Monoclonal Antibody Followed by Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Metastatic Breast Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2001

Conditions
Breast Cancer
Interventions
BIOLOGICAL

filgrastim

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

yttrium Y 90 monoclonal antibody B3

Trial Locations (2)

20892

Center for Cancer Research, Bethesda

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00020410 - Radiolabeled Monoclonal Antibody Followed by Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter